HOME >> BIOLOGY >> NEWS
Genetic variants put some patients at risk for particular drug reactions

Genetic variants in the human enzyme that metabolizes the drug warfarin, the frequently prescribed anticoagulant Coumadin, make some patients more susceptible to serious or life-threatening bleeding.

In an article in the April 3, 2002, edition of the Journal of the American Medical Association, Dr. David Veenstra, assistant professor in the University of Washington School of Pharmacy, and his colleagues say that the two genetic variants, CYP2C9*2 and CTP2C9*3, are relatively common. This is one of the first studies to show an association between genetic variants and the risk of a serious adverse drug reaction.

The patients in the retrospective cohort study attended one of two anticoagulation clinics in the Seattle area and received warfarin to prevent blood clotting due to conditions such as atrial fibrillation (irregular heart rhythm).

"After we identified these patients' genotypes, we looked back at their medical records to determine if they had had severe bleeding incidents while they were taking warfarin," Veenstra said. "We looked at two specific variants in the gene for the enzyme that helps patients metabolize warfarin."

Compared to other patients, those with at least one of the genetic variants required more time to achieve stable dosing. In other words, it took a longer period of time to determine an effective and safe dose.

Additionally, patients with at least one of the two genetic variants had a significantly increased occurrence of a serious or life-threatening bleeding incident. Veenstra says that the small numbers of patients (58) with the genetic variants in the 185-person study group suggests caution in interpreting the study's results -- but that screening for these variants may allow clinicians to develop dosing protocols and surveillance techniques to reduce the risk of adverse drug reactions in warfarin patients.

"Warfarin is a very important drug for preventing blood clo
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
2-Apr-2002


Page: 1 2

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
11. Genetic discovery could dramatically reduce need for liver transplants in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... 22, 2020 , ... The field of quantitation of large molecules or proteins ... this area. However, the use of mass spectrometry in this field has gained a ... “How do you choose which approach to use (LBA or MS)?” In many ...
(Date:6/23/2020)... ... 23, 2020 , ... In its June 22 online post, business and technology ... Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex . ... that starting July 5 it would begin offering free tissue stem cell ...
(Date:6/19/2020)... , ... June 18, 2020 ... ... webinar series, “Automate Your Lab with Software for Data Decisions,” for pharmaceutical ... learn how to integrate and automate cutting-edge scientific instruments and laboratory equipment ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... 2020 , ... Join experts from Reed Tech , Gary Saner, Sr. ... one hour live webinar on Thursday, August 13, 2020 at 11am EDT ... medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical device ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced ... Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the ... awards program, highlighting outstanding examples of how technology innovations and strategic initiatives can ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... racing to develop a vaccine or drug treatment. In an effort to better ... has publicly released the world’s largest imaging dataset portraying therapeutic compound effects from ...
Breaking Biology Technology:
Cached News: